Feds Approve Large-Scale Weed Making for Clinical Trials
Published Date: 2/13/2026
Notice
Summary
Scottsdale Research Institute wants to make large amounts of marijuana and related substances for clinical trials and customers. People who already make or use these drugs can comment or ask for a hearing by April 14, 2026. This move could speed up research and distribution, but no other drug activities are allowed under this registration.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Application to Bulk Manufacture Schedule I Cannabis
Scottsdale Research Institute applied on January 8, 2026 to be registered as a bulk manufacturer of Marihuana Extract (code 7350), Marihuana (code 7360), and Tetrahydrocannabinols (code 7370), all listed in Schedule I. The company says it plans to bulk manufacture those substances to support clinical trials and to distribute to its customers.
Comment and Hearing Deadline for Stakeholders
Registered bulk manufacturers of the affected basic classes and applicants may submit electronic comments or objections, and may file a written request for a hearing, on or before April 14, 2026. Comments must be submitted through https://www.regulations.gov and submitters will receive a Comment Tracking Number.
Registration Limited to Manufacturing Only
The notice states that no other activities for the listed drug codes are authorized under this registration. If registered, Scottsdale Research Institute would only be authorized for bulk manufacture of the listed substances.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in